Brain Cancer Research - Symptoms, Benign and Malignant Tumors, Gliomas, Treatment

Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.


Brain Cancer Research Today

Home

View Latest Issue

Information About Brain Cancer

Books on Brain Cancer

Advertising in Research Today

View Other Research Today Publications



Survival of patients with adult medulloblastoma: a population-based study.

Lai R

Neurological Institute of Columbia University, New York, New York 10032, USA. rlai@neuro.columbia.edu

BACKGROUND: Adult medulloblastoma accounts for less than 1% of adult intracranial tumors. Previous survival studies have been inconclusive because of small sample sizes and patient ascertainment bias. METHODS: The Surveillance, Epidemiology, and End Results (SEER) 17 registries database, released April 2007, was used to assess survival rates and prognostic factors in this disease. SEER*Stat was used to calculate observed and relative 2-, 5-, 10-, 15-, and 20-year survival and Cox Proportion Hazard Regression modeling was used to evaluate prognostic variables. RESULTS: Four hundred fifty-four patients with adult medulloblastoma were diagnosed from 1973-2004 in the 17 regions covered by SEER. The 2-, 5-, and 10-year relative survival rates were 79.9, 64.9, and 52.1%, respectively. The overall median survival was 127 months (10.6 years). The survival of this disease has improved in the last 3 decades. The median survival of those diagnosed <or= 1980 and from 1981-1990 were 39 (3.3 years) and 127 months (10.6 years), respectively, and has not been reached for those diagnosed from 1991-2000 and after 2000. In multivariable regression modeling, diagnoses after the 1980s, age of diagnosis before 20, gross total resection, and radiation were favorable prognostic factors, whereas large cell histology was associated with poor survival. CONCLUSIONS: This is the largest and most representative survival study to date, but further assessments are needed to evaluate the potential of using molecular genetic markers, together with clinical and histopathologic variables, in predicting survival. This may have to take place in the context of a large consortium.

Published 25 March 2008 in Cancer, 112(7): 1568-74.
Full-text of this article is available online (may require subscription).

Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Brain Cancer Research Today. All Rights Reserved.



Brain Cancer Research Today Archive:

Volume 1 (2004)
  Issue 1 (August)
  Issue 2 (September)
  Issue 3 (October)
  Issue 4 (November)
  Issue 5 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)



Brain Cancer Books

Ya Gotta Believe: My Roller-Coaster Life As a Screwball Pitcher and Part-Time Father, and My Hope-Filled Fight Against Brain Cancer

Ya Gotta Believe: My Roller-Coaster Life As a Screwball Pitcher and Part-Time Father, and My Hope-Filled Fight Against Brain Cancer